Comparison of the efficacy of third-line treatments for metastatic colorectal cancer: A network meta-analysis

被引：0
|
作者：
Taieb, J. [1 ]
Yahiaoui, S. [2 ]
Choucair, E. [3 ]
Yao, W. [4 ]
Hauch, O. [2 ]
机构：
[1] Hop European George Pompidou, Gastroenterol & Digest Oncol Dept, Paris, France
[2] Lab Servier SAS, Global Value Access & Pricing Dept, Suresnes, France
[3] Lab Servier SAS, Med Affairs, Suresnes, France
[4] Servier Pharmaceut, Dept Clin Res, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.071
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
60P
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [31] Current Options for Third-Line Treatment of Metastatic Colorectal Cancer: Discussion
    Grothey, Axel
    Marshall, John L.
    Seery, Tara E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 13 - 14
  • [32] Efficacy of First-Line CLL Treatments in Comparison to Chlorambucil: A Network Meta-Analysis
    Firwana, Belal
    Sonbol, Mohamad Bassam
    Atrash, Shebli
    Ravilla, Rahul
    Raval, Mihir
    Hao, Lin
    Jethava, Yogesh
    Veeraputhiran, Muthu
    Makhoul, Issam
    Sasapu, Appalanaidu
    BLOOD, 2016, 128 (22)
  • [33] A systematic review and network meta-analysis of the efficacy and safety of third-line and over third-line therapy after imatinib and TKI resistance in advanced gastrointestinal stromal tumor
    Xiao, Xianhao
    Yuan, Weiye
    Wang, Chong
    Song, He
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [34] Third-line chemotherapy in advanced gastric cancer A systematic review and meta-analysis
    Zheng, Yu
    Zhu, Xu-Qing
    Ren, Xiao-Gang
    MEDICINE, 2017, 96 (24)
  • [35] Cost-effectiveness analysis of fruquintinib for metastatic colorectal cancer third-line treatment in China
    Zhi Peng
    Xingduo Hou
    Yangmu Huang
    Tong Xie
    Xinyang Hua
    BMC Cancer, 20
  • [36] Comparison of CAR T-cell and bispecific antibody as third-line or later-line treatments for multiple myeloma: a meta-analysis
    Liang, Xiaojie
    Wang, Yufan
    Luo, Baiwei
    Lin, Bingyu
    Lu, WeiXiang
    Tian, Shengyu
    Liu, Dan
    Wang, Liang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [37] Cost-effectiveness analysis of fruquintinib for metastatic colorectal cancer third-line treatment in China
    Peng, Zhi
    Hou, Xingduo
    Huang, Yangmu
    Xie, Tong
    Hua, Xinyang
    BMC CANCER, 2020, 20 (01)
  • [38] Cost-effectiveness analysis of fruquintinib as third-line treatment for patients with metastatic colorectal cancer
    Zhang, Peng-Fei
    Xie, Dan
    Li, Qiu
    TUMORI JOURNAL, 2020, 106 (05): : 400 - 405
  • [39] The efficacy of panitumumab in refractory metastatic colorectal cancer: A meta-analysis
    Duan, Kun-Feng
    Wang, Hua
    JOURNAL OF BUON, 2019, 24 (04): : 1457 - 1463
  • [40] Efficacy of Targeted Therapies in Metastatic Colorectal Cancer: Meta-Analysis
    Gouverneur, Amandine
    Arnaud, Mickael
    Berdai, Driss
    DeBoissieu, Paul
    Fourrier-Reglat, Annie
    Noize, Pernelle
    Salvo, Francesco
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 363 - 364
12345